PHARVARIS N V
PHVS·N69605108·US·Common Stock·Healthcare - Biotechnology-13D/G
PHVS (PHARVARIS N V) is held by 57 institutional investors as of Q1 2026. Largest holders: FMR LLC ($177.5M), VIKING GLOBAL INVESTORS LP ($103.2M), WELLINGTON MANAGEMENT GROUP LLP ($59.9M). Net institutional sentiment: Mixed.
57
Holders
Avg rating(9 Elite)
$525.2M
Total Value
46% (60)
Fund Consensus
22 buying - 26 selling
Who's Trading
InsiderNANijdam AnnaSell $82KJun 4, 2026
InsiderBEBjork ElisabethSell $293KMay 20, 2026
InsiderMBModig BerndtSell $67KMay 18, 2026
InsiderSWSouverijns WimSell $299KMay 15, 2026
InsiderGRGlassman RobertSell $159KMay 15, 2026
InsiderGRGlassman RobertSell $139KMay 15, 2026
InsiderLPLu PengExercise 14K shMay 1, 2026
InsiderLPLu PengSell $423KMay 1, 2026
ActivistBLBain Capital Life Sciences Fund, L.P.2.5%Feb 17, 2026
13F: Insider & Congress:
Showing 1-20 of 60
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer